ST. PETERSBURG, FL -- (MARKET WIRE) -- 06/06/06 -- Hathaway Corporation (PINKSHEETS: HWYI) is pleased to announce the filing of international patent on "METHOD AND COMBINATION ELECTRONIC COMMUNICATION AND MEDICAL DIAGNOSTIC APPARATUS FOR DETECTING/MONITORING NEUROPATHY" for Diabetes Detection, Inc. (DDI). The patents are currently being filed in Canada, China (including HK), Europe, India, Japan and South Korea. Hathaway investors can access DDI's website for additional information.

Diabetes Detection, Inc. owns the exclusive license for the patent pending Vibrameter, which utilizes current hand-held communication devices for use in the early detection of diabetes. The website can be accessed at; http://www.diabetesdetectioninc.com.

The Vibrameter has the dual functions of electronic communication, such as a beeper/pager or cellular phone, as well as a medical diagnostic tool for detecting and/or monitoring neuropathy. The Device allows a health care professional to perform a quick and accurate test to determine neuropathy in patients. The Device produces instant results allowing the health care professional to refer the subject for further diagnostic evaluation, thereby assisting in the early detection of diabetes.

About Hathaway Corporation

Hathaway Corporation develops and acquires undervalued companies that bring a shift in how communications are delivered and serviced globally. Hathaway continues to seek out and capitalize on emerging technologies. Their first acquisition, OptiCon Systems, was first developed by Corning and sold to their customers. Corning spent millions of dollars and over seven years developing the Fiber Optic Management System currently marketed and sold by OptiCon Systems Inc. OptiCon serves over 70% of the global 500 companies such as Adelphia, Charter, Comcast, Comcast/AT&T, Cox, Time Warner, and BrightHouse. Through Companies like OptiCon, Hathaway brings the communication solutions of the future to today's business marketplace.

Safe Harbor

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact:
FutureTechIR for Hathaway Corporation
Investor Relations
817-812-2105
727-417-9338